Evidence map›Paper›PMID 41969630›Full record

ArticleMedComm2026

Multimodal Deep Learning for Pulmonary Nodule Detection on Chest Radiography in High-Risk Adults, With Secondary Validation for All-Cause and Cause-Specific Mortality Prediction: A Multicenter Cohort Study.

Junxian Li, Yuchen Xing, Ximin Gao, Ya Liu, Liwen Zhang, Yubei Huang, Pengyu Zhang, Zhaoxiang Ye, Meng Wang, Fengju Song

Abstract read
In one paragraph

Article in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Junxian LiDepartment of Blood Transfusion Key Laboratory of Cancer Prevention and Therapy in Tianjin National Clinical Research Center for Cancer Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin Medical University Tianjin China.
Yuchen XingDepartment of Cancer Epidemiology and Biostatistics, Tianjin Key Laboratory of Molecular Cancer Epidemiology, Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin China.
Ximin GaoDepartment of Cancer Epidemiology and Biostatistics, Tianjin Key Laboratory of Molecular Cancer Epidemiology, Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin China.
Ya LiuPublic Health Science and Engineering College Tianjin University of Traditional Chinese Medicine Tianjin China.
Liwen ZhangDepartment of Epidemiology and Statistics, School of Public Health Hebei Medical University, Hebei Key Laboratory of Environment and Human Health Shijiazhuang China.
Yubei HuangDepartment of Cancer Epidemiology and Biostatistics, Tianjin Key Laboratory of Molecular Cancer Epidemiology, Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin China.
Pengyu ZhangDepartment of Blood Transfusion Key Laboratory of Cancer Prevention and Therapy in Tianjin National Clinical Research Center for Cancer Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin Medical University Tianjin China.
Zhaoxiang YeDepartment of Radiology National Clinical Research Centre for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin China.
Meng WangDepartment of Lung Cancer, Key Laboratory of Cancer Prevention and Therapy National Clinical Research Center for Cancer Tianjin's Clinical Research Center for Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin China.
Fengju SongDepartment of Cancer Epidemiology and Biostatistics, Tianjin Key Laboratory of Molecular Cancer Epidemiology, Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center For Cancer Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chest radiographs (CXRs) may encode prognostic signals beyond pulmonary nodule detection. We developed LungProNet, a multimodal deep-learning (DL) model that fuses CXR features with four epidemiologic variables (age, sex, smoking history, and family history) for pulmonary nodule detection as the primary task, with secondary validation for all-cause and cause-specific mortality prediction. LungProNet was trained and internally validated on Tianjin Lung Cancer Imaging Dataset (TLCID) (70/30;

Indexed as

chest X‐raydeep learninglung cancer screeningmortality predictionpulmonary nodule

Identifiers

PMID41969630
PMCPMC13062638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.